Heart failure risk prediction improves when gut-derived biomarkers are added to traditional models, revealing residual risk ...
Zurich, Zurich - April 10, 2026 - PRESSADVANTAGE - IntroDrink, the Swiss premium natural health retailer, has expanded ...
Washington: The researchers at the University of Chicago have uncovered a surprising new role for zeaxanthin, a plant-based ...
Both protein and fiber are in the spotlight right now for good reason. But which should you prioritize? Dietitians explain ...
Awarded to Dr Hayley Lavender (pictured right) and Dr Paraskevi (Pari) Kritsiligkou, the awards support biomedical ...
Two researchers from the University of Liverpool's Faculty of Health and Life Sciences have been awarded prestigious ...
A common eye-health nutrient, zeaxanthin, may also help the body fight cancer more effectively. Scientists discovered it strengthens T cells and enhances the impact of immunotherapy treatments. Found ...
EMPAVELI (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced ...
Alexion to deliver 20 presentations across gMG, NF1 plexiform neurofibromas and neuromyelitis optica spectrum disorder at AAN meeting: Cambridge, UK Saturday, April 11, 2026, 18:0 ...
Microbial infections, caused by bacteria, viruses, and parasites, pose a significant challenge to global health, affecting millions annually. Despite advancements in medical science, understanding the ...
CancerBuddy connects cancer patients, survivors and caregivers with empathetic care navigators, workplace and peer ...
RNA therapies present significant opportunities in targeting a broad range of diseases through various innovative approaches, including antisense oligonucleotides, siRNAs, mRNA vaccines, and aptamers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results